Table 2.
Alterations of gut microbiota compositions associated with Parkinson’s disease.
Comparisona | Microbiota | Sample | Mechanism | Ref. |
---|---|---|---|---|
PD patients vs Healthy control | Proteus sp.↑ Bilophila sp.↑and Roseburia sp.↑Lachnospiraceae↓Rikenellaceae↓ Peptostreptococcaceae↓Butyricicoccus sp. ↓ | Stool | SCFA-producing families decrease | (Scheperjans et al., 2015) |
PD patients vs Healthy control | Lactobacillus↓Prevotellaceae↓ Peptostreptococcus↓ Butyricicoccus spp.↓Proteus↑ Enterobacter spp.↑ | Stool | Decreased Prevotellace lead to increased intestinal permeability, systemic exposure of bacterial endotoxins | (Sampson et al., 2016) |
PD patients vs Healthy control |
Firmicutes ↓ Prevotella ↑ Faecalibacterium ↓ |
Stool | SCFA-producing taxon decrease | (Heinzel et al., 2020) |
PD patients vs Healthy control | Ralstonia↑Proteobacteria↑ Enteococcaceae↑Blautia, Coprococcus↓, Roseburia↓and Faecalibacterium↓ | Stool | Pro-inflammatory cytokine producing bacteria increased, anti-inflammatory bacteria decreased | (Keshavarzian et al., 2015) |
PD patients vs Healthy control | Helicobacter pylori↑ | Stool | Helicobacter pylori is a triggering factor in PD pathogenesis | (Çamcı and Oğuz, 2016) |
PD patients vs Healthy control |
Bacteroides fragilis ↓ Bifidobacterium↓ |
Stool | Bacteroides fragilis were related with worsening of motivation/activeness and Bifidobacterium was associated to hallucinations/delusions | (Minato et al., 2017) |
PD patients vs Healthy control |
Porphyromonas↑Corynebacterium↑, Prevotella, ↑Porphyromonas, ↑ Ruminococcaceae ↓Lachnospiraceae↓ Lactobacillus ↑Bifidobacteria↑ |
Stool | Opportunistic pathogens were increased, SCFAs producing bacteria reduced, probiotics with carbohydrate-metabolizing increased | (Wallen et al., 2020) |
PD patients vs Healthy control | Akkermansia↑ Catabacter ↑Akkermansiaceae↑Roseburia, ↓Faecalibacterium↓ Lachnospiraceae↓ | Stool | Akkermansia can increase the permeability of intestine, lead to α-syn fibrils aggregate in intestine butyrate producing bacteria decrease | (Nishiwaki et al., 2020) |
PD patients vs Healthy control |
Christensenellaceae, ↑Desulfovibrionaceae↑Bifidobacterium↑Bilophila↑Akkermansia↑ Lachnospiraceae↓Roseburia↓, Faecalibacterium↓ |
Stool, serum | Carbohydrate fermentation reduced, low butyrate synthesis capacity proteolytic fermentation and deleterious amino acid metabolites production increased | (Cirstea et al., 2020) |
PD patients vs Healthy control | Bacteroidetes ↓Prevotellaceae ↓Enterobacteriaceae↑ | Stool | SCFAs may induce ENS alterations and dysmotility of gastrointestinal in PD | (Unger et al., 2016) |
PD patients vs Healthy control | Lactobacillus casei shirota ↓staphylococci ↑ | Stool | Lactobacillus casei shirota can improve the bowel movement by decreasing the number of staphylococci in PD patients | (Cassani et al., 2011) |
PD patients vs Healthy control | Bacillus spp.↓ | Stool | convert L-tyrosine to L-DOPA | (Surwase and Jadhav, 2011) |
PD mice vs Healthy control |
Proteobacteria↑ Turicibacterales↑Enterobacteriales↑ Firmicutes↓ Clostridiales↓ |
Stool | Fecal SCFAs concentration decrease, increase DA and 5-HT levels, reduce activation of microglia and astrocytes | (Sun et al., 2018) |
A comparison of condition A vs condition B; ↑, increase in condition A related to condition B; ↓, decrease in condition A related to condition B.